• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Expression of CD123 and CD114 on the bone marrow cells of patients with myelodysplastic syndrome

摘要:

Background Recent studies have shown that interleukin-3 receptor α (CD123) is highly expressed on leukemia stem cells of patients with acute myeloid leukemia, and is correlated with tumor load and poor prognosis.The expression of CD123 may also be high in patients with myelodysplastic syndrome (MDS).In this study, the expression and clinical significance of CD123 and granulocyte colony stimulating factor (G-CSF) receptor (CD114) on the bone marrow cells of patients with MDS were investigated to explore the molecular marker of the malignant clone of MDS.Methods Forty-two patients with MDS, who were diagnosed in the Hematological Department of General Hospital of Tianjin Medical University from 2008 to 2009, and twelve normal controls were enrolled in this study.Fluorescence activiated cell sorter (FACS) was used to measure the expression of CD123 on CD34+CD38- cells and CD114 on CD34+cells of the bone marrow of these patients and controls and the clinical significance was analyzed.The expression of CD114 on CD123+CD34+CD38- cells was further measured to explore the molecular marker of the malignant clone in MDS.Results MDS patients displayed significantly higher proportion of CD34+CD38-/CD34+ ((14.03±5.27)%) than normal controls ((7.70±4.36)%, P <0.05).The expression rate of CD123+CD34+CD38-/CD34+CD38- was significantly higher in MDS patients ((48.39±28.15)%) than that in normal controls ((8.75±11.71)%, P <0.01).The expression level of CD123 was significantly correlated with the proportion of bone marrow blasts (r=0.457, P <0.05).The expression rate of CD114+CD34+/CD34+ was lower in MDS patients ((33.05±21.71)%) than that in normal controls ((38.99±19.07)%) but was not statistically significant (P >0.05).The expression of CD114 on CD123+CD34+CD38- cells ((34.82±29.58)%) was significantly lower than that on CD123-CD34+CD38- cells ((53.48±27.41)%) of M DS patients (P <0.05).Conclusions MDS patients displayed higher proportion of CD34+CD38-/CD34+ than normal controls.CD123 was highly expressed in the bone marrow of the patients with MDS, significantly correlated with the proportion of bone marrow blasts, and thus might be the marker of MDS malignant clone.CD123+CD34+CD38- cells exhibited lower expression of G-CSF receptors, which might partly explain why MDS clone responds worse to G-CSF in vitro and in vivo.

更多
期刊: 《中华医学杂志(英文版)》2010年123卷15期 2034-2037页 SCIMEDLINEISTICCSCDBP
分类号: R5
DOI: 10.3760/cma.j.issn.0366-6999.2010.15.015
发布时间: 2010-08-30
基金项目:
This study was supported by the grants from Tianjin Science and Technology Supporting Program "11th Five-Year Plan" National Key Technology R&D Program Ph.D.Programs Foundation of the Ministry of Education of China Tianjin Application Bases and Advanced Technology Research Program
翻译满意度评价:
提交
  • 浏览:213
  • 下载:16

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷